The concept of using bispecific antibodies for cancer therapy by
retargeting immune effector cells was developed several years ago.
Initial clinical studies were rather disappointing mainly due to
low efficacy, severe side effects and the immunogenicity of the
bispecific antibodies. The progress in antibody engineering finally
led to the generation of new classes of bispecific antibodies
lacking these obstacles. In addition, new applications were
established, such as pre-targeting strategies in radioimmunotherapy
and dual targeting approaches in order to improve binding,
selectivity and efficacy.
In this book, the different ways of generating bispecific
antibodies are described, with emphasis on recombinant formats. The
various applications of bispecific antibodies, e.g. in cellular
cancer immunotherapy, radioimmunotherapy and pretargeting
strategies are covered, and emerging applications such as dual
targeting strategies, which involve the simultaneous inhibition of
two targets, are addressed.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!